References
- Arakawa M. Complete inhibition of mouse lymphoid leukemia L-1210 by car bazilquinone. GANN 1972; 64: 487–489
- Fujimoto S., Endoh F., Kitsukawa Y., Morimoto Y., Sugibayashi K., Miyakawa A., Suzuki H. Continued in vitro and in vivo release of an antitumor drug from albumin microspheres. Experientia 1983; 39: 913–916
- Gornall A. G., Bardawill C. J., David M. M. Determination of serum proteins by means of biuret reactions. Journal of Biological Chemistry 1949; 177: 751
- Goto S., Nakajima J., Tsuruta M., Sato H., Nakayama T., Aoyama T., Shibuya M., Sugiyama M. Bioavailability of aspirin from microcapsules dosage form. Yakuzaigaku 1976; 36: 152–159
- Kato T., Nemoto R., Mori H., Takahashi M., Tamakawa Y., Harada M. Arterial chemoembolization with microencapsulated anticancer drug. Journal of the American Medical Association 1981; 245: 1123–1127
- Nakao H., Arakawa M., Nakamura T., Fukushima M. Anti-leukemic agents. II New 2, 5-bis(l-aziridinyl)-P-benzoquinone derivatives. Chemical and Pharmaceutical Bulletin 1972; 20: 1968–1979
- Schwick H. G., Heide K. Immunochemistry and immunology of collagen and gelatin. Bibliotheca Haematologica 1969; 33: 111–125, No
- Sjovall J., Sjoqvist R., Heitfeldt B., Nyquist H. Correlation between the bioavailability of microencapsulated Bacampicillin in suspension and in vitro micro capsule dissolution. Journal of Pharmaceutical Sciences 1984; 73: 141–145
- Takeda Y., Nambu N., Nagai T. Microencapsulation and bioavailability in beagle dogs of Indomethacin. Chemical and Pharmaceutical Bulletin 1981; 29: 264–267
- Wood P. D. Technical and pharmaceutical uses of gelatin. The Science and Technology of Gelatin, A. G. Ward, A. Courts. Academic Press, New York 1977; 415–418